Passeron, T., Gérard, A., Doyen, J., Cremoni, M., Bailly, L., Zorzi, K., . . . Seitz-Polski, B. Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients. BMJ Publishing Group.
Chicago Style (17th ed.) CitationPasseron, Thierry, et al. Baseline and Early Functional Immune Response Is Associated with Subsequent Clinical Outcomes of PD-1 Inhibition Therapy in Metastatic Melanoma Patients. BMJ Publishing Group.
MLA (9th ed.) CitationPasseron, Thierry, et al. Baseline and Early Functional Immune Response Is Associated with Subsequent Clinical Outcomes of PD-1 Inhibition Therapy in Metastatic Melanoma Patients. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.